In obesity, adipocyte levels of PU.1 are significantly increased and thus further understanding the aberrant transcriptional changes mediated by PU.1 may provide important therapeutic targets in the treatment of obesity-induced insulin resistance. The gene discussed is SPI1; the disease is obesity disorder.